APA Citation

Reardon, D., Molinaro, A., Peters, K., Clarke, J., Jordan, J., de Groot, J., . . . Nayak, L. (2020). CTIM-32. PHASE II AND BIOMARKER STUDY OF PEMBROLIZUMAB OR PEMBROLIZUMAB PLUS BEVACIZUMAB FOR RECURRENT GLIOBLASTOMA PATIENTS. Neuro Oncol.

Citação norma Chicago

Reardon, David, et al. "CTIM-32. PHASE II AND BIOMARKER STUDY OF PEMBROLIZUMAB OR PEMBROLIZUMAB PLUS BEVACIZUMAB FOR RECURRENT GLIOBLASTOMA PATIENTS." Neuro Oncol 2020.

MLA Citation

Reardon, David, et al. "CTIM-32. PHASE II AND BIOMARKER STUDY OF PEMBROLIZUMAB OR PEMBROLIZUMAB PLUS BEVACIZUMAB FOR RECURRENT GLIOBLASTOMA PATIENTS." Neuro Oncol 2020.

Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.